EMEA-001418-PIP02-15-M01

Key facts

Active substance
Cabotegravir
Therapeutic area
Infectious diseases
Decision number
P/0321/2017
PIP number
EMEA-001418-PIP02-15-M01
Pharmaceutical form(s)
  • Suspension for injection
  • Tablet
Condition(s) / indication(s)
Prevention of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
  • Tablet
  • Age-appropriate oral dosage form
  • Suspension for injection
Contact for public enquiries
ViiV Healthcare UK Limited
Tel. +44 (0)208 990 3650
E-mail: eu.paediatric-plans@gsk.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating